NEO-POLYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Neo-polycin patents expire, and what generic alternatives are available?
Neo-polycin is a drug marketed by Dow Pharm and is included in two NDAs.
The generic ingredient in NEO-POLYCIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEO-POLYCIN?
- What are the global sales for NEO-POLYCIN?
- What is Average Wholesale Price for NEO-POLYCIN?
Summary for NEO-POLYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| DailyMed Link: | NEO-POLYCIN at DailyMed |
US Patents and Regulatory Information for NEO-POLYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dow Pharm | NEO-POLYCIN | bacitracin zinc; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 060647-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dow Pharm | NEO-POLYCIN | gramicidin; neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 060427-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
